von Tengg-Kobligk H - Search Results

1

Generation of Stable cisPt Resistant Lung Adenocarcinoma Cells.

Ruprecht N, Hofmann L, Hungerbühler MN, Kempf C, Heverhagen JT, von Tengg-Kobligk H. Ruprecht N, et al. Pharmaceuticals (Basel). 2020 May 29;13(6):109. doi: 10.3390/ph13060109. Pharmaceuticals (Basel). 2020. PMID: 32485798 Free PMC article.

2

Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis.

Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, McAuliffe MJ, Levine AL, Rosol TJ, Knopp MV. Jia G, et al. Invest Radiol. 2005 Apr;40(4):243-8. doi: 10.1097/01.rli.0000156312.24604.7c. Invest Radiol. 2005. PMID: 15770143

3

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.

Jia G, Heverhagen JT, Henry H, Polzer H, Baudendistel KT, von Tengg-Kobligk H, Levine AL, Rosol TJ, Knopp MV. Jia G, et al. Magn Reson Imaging. 2006 Jul;24(6):721-5. doi: 10.1016/j.mri.2005.12.029. Epub 2006 Mar 24. Magn Reson Imaging. 2006. PMID: 16824967

4

Contrast agents and ionization with respect to safety for patients and doctors.

von Tengg-Kobligk H, Kara L, Klink T, Khanicheh E, Heverhagen JT, Böhm IB. von Tengg-Kobligk H, et al. Contrib Nephrol. 2015;184:59-74. doi: 10.1159/000365823. Epub 2015 Feb 9. Contrib Nephrol. 2015. PMID: 25676292

5

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential.

Wei W, Jia G, von Tengg-Kobligk H, Heverhagen JT, Abdel-Rahman M, Wei L, Christoforidis JB, Davidorf F, Knopp MV. Wei W, et al. J Comput Assist Tomogr. 2017 Sep/Oct;41(5):823-827. doi: 10.1097/RCT.0000000000000598. J Comput Assist Tomogr. 2017. PMID: 28448404 Free article.

6

Ex vivo performance comparison of three percutaneous biopsy needle systems.

Krokidis M, Hungerbühler M, Hewer E, Heverhagen J, von Tengg-Kobligk H. Krokidis M, et al. Eur Radiol. 2019 Aug;29(8):4044-4049. doi: 10.1007/s00330-018-5960-7. Epub 2019 Jan 14. Eur Radiol. 2019. PMID: 30643943 Free article.

7

Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent.

Bower DV, Richter JK, von Tengg-Kobligk H, Heverhagen JT, Runge VM. Bower DV, et al. Invest Radiol. 2019 Aug;54(8):453-463. doi: 10.1097/RLI.0000000000000567. Invest Radiol. 2019. PMID: 31265439 Free article.

8

A survey on the future of radiology among radiologists, medical students and surgeons: Students and surgeons tend to be more skeptical about artificial intelligence and radiologists may fear that other disciplines take over.

van Hoek J, Huber A, Leichtle A, Härmä K, Hilt D, von Tengg-Kobligk H, Heverhagen J, Poellinger A. van Hoek J, et al. Eur J Radiol. 2019 Dec;121:108742. doi: 10.1016/j.ejrad.2019.108742. Epub 2019 Nov 9. Eur J Radiol. 2019. PMID: 31734640

9

Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures.

Galé A, Hofmann L, Lüdi N, Hungerbühler MN, Kempf C, Heverhagen JT, von Tengg-Kobligk H, Broekmann P, Ruprecht N. Galé A, et al. Int J Mol Sci. 2021 Aug 31;22(17):9468. doi: 10.3390/ijms22179468. Int J Mol Sci. 2021. PMID: 34502377 Free PMC article.

10

¹H HR-MAS NMR Based Metabolic Profiling of Lung Cancer Cells with Induced and De-Induced Cisplatin Resistance to Reveal Metabolic Resistance Adaptations.

Vermathen M, von Tengg-Kobligk H, Hungerbühler MN, Vermathen P, Ruprecht N. Vermathen M, et al. Molecules. 2021 Nov 9;26(22):6766. doi: 10.3390/molecules26226766. Molecules. 2021. PMID: 34833859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page